Skip to main content
Year archive

HLB Life Science CO.,LTD. — 2021 filings

All 32 regulatory filings released by HLB Life Science CO.,LTD. (067630) in 2021, sourced directly from the official regulator.

32 Filings
2021 Period
2021 filings (32)
Filing Released Lang
주요사항보고서(신주인수권부사채권발행결정)
Capital/Financing Update
2021-12-28 Korean
증권신고서(채무증권)
Capital/Financing Update
2021-12-28 Korean
타법인주식및출자증권취득결정(자율공시)
M&A Activity
2021-12-27 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings
2021-12-16 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2021-12-10 Korean
[기재정정]사업보고서 (2018.12)
Audit Report / Information FY 2018
2021-12-01 Korean
[기재정정]사업보고서 (2019.12)
Audit Report / Information FY 2019
2021-12-01 Korean
분기보고서 (2021.09)
Interim / Quarterly Report 9M 2021
2021-11-12 Korean
전환청구권행사
Share Issue/Capital Change
2021-10-15 Korean
투자판단관련주요경영사항(이전 치료력이 없는 진행성 또는 전이성 위암 및 위식도 접합부암 환자를 대상으로 캄렐리주맙+카페시타빈/옥살리플라틴 병용투여 후 리보세라닙+캄렐리주맙 투여에 대한 제2상 임상시험 계획(IND) 승인)
Regulatory Filings
2021-09-10 Korean
반기보고서 (2021.06)
Interim / Quarterly Report H1 2021
2021-08-12 Korean
분기보고서 (2021.03)
Interim / Quarterly Report Q1 2021
2021-05-14 Korean
[기재정정]단일판매ㆍ공급계약체결
Regulatory Filings
2021-04-30 Korean
투자판단관련주요경영사항(진행성 또는 전이성 위암 및 위식도접합부암 환자 대상 1차 치료로 캄렐리주맙과 카페시타빈/옥살리플라틴 병용 투여 후 리보세라닙(아파티닙)과 캄렐리주맙 병용투여, 3상 임상시험 계획(IND) 승인 신청)
Legal Proceedings Report
2021-04-19 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2021-03-31 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information
2021-03-31 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Major Shareholding Notification
2021-03-26 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2021-03-26 Korean
감사보고서제출
Audit Report / Information FY 2020
2021-03-23 Korean
[기재정정]의결권대리행사권유참고서류
Proxy Solicitation & Information Statement
2021-03-23 Korean
[기재정정]주주총회소집공고
AGM Information
2021-03-23 Korean
사업보고서 (2020.12)
Audit Report / Information FY 2020
2021-03-23 Korean
권리락(무상증자)
Share Issue/Capital Change
2021-03-12 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information
2021-03-02 Korean
주요사항보고서(무상증자결정)
Share Issue/Capital Change
2021-02-26 Korean
주권매매거래정지(무상증자)
Share Issue/Capital Change
2021-02-26 Korean
주주명부폐쇄기간또는기준일설정
Share Issue/Capital Change
2021-02-26 Korean
주주총회소집결의
Proxy Solicitation & Information Statement
2021-02-25 Korean
주주총회집중일개최사유신고
AGM Information
2021-02-25 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement
2021-02-25 Korean
주주총회소집공고
AGM Information
2021-02-25 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release FY 2020
2021-02-15 Korean